Ross Jeggo
Senior Vice President, Global Neurology Research Biogen
Seminars
Wednesday 2nd December 2026
Fireside Chat: Building the Next Generation of CNS Pipelines Through Brain Delivery & Modality Innovation
9:50 am
- Determining which brain delivery technologies and therapeutic modalities warrant integration into long-term neuroscience portfolios
- Establishing evidence thresholds for advancing CNS delivery platforms from discovery-stage innovation into clinical development
- Balancing investments across internal R&D, platform partnerships, licensing opportunities, and external innovation ecosystems
- Identifying the biological, translational, and regulatory advances most likely to unlock the next wave of CNS therapeutic development
Wednesday 2nd December 2026
Panel Discussion: The Investment Landscape for CNS Delivery Technologies: Trends, Drivers & Funding Priorities
3:40 pm
- Assess where capital is concentrating across CNS delivery modalities and identify the key scientific and commercial drivers behind investment decisions
- Define the target product profiles and competitive advantages that make CNS delivery platforms attractive for partnerships and acquisition
- Evaluate the timelines, capital requirements, and key inflection points for advancing CNS delivery technologies from preclinical development to clinical validation
- Examine how cost-of-goods, scalability, and risk profiles influence long-term commercial viability and investor confidence
